Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1970 1
1972 1
1973 1
1974 2
1975 6
1977 3
1979 4
1980 3
1982 1
1983 6
1984 8
1985 12
1986 17
1987 4
1988 3
1989 6
1990 6
1991 12
1992 5
1993 7
1994 5
1995 9
1996 12
1997 4
1998 10
1999 4
2000 4
2001 9
2002 9
2003 12
2004 13
2005 20
2006 20
2007 16
2008 32
2009 36
2010 28
2011 39
2012 56
2013 50
2014 50
2015 35
2016 29
2017 35
2018 39
2019 52
2020 60
2021 63
2022 58
2023 68
2024 54

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

913 results

Results by year

Filters applied: . Clear all
Page 1
Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade.
Gu SS, Zhang W, Wang X, Jiang P, Traugh N, Li Z, Meyer C, Stewig B, Xie Y, Bu X, Manos MP, Font-Tello A, Gjini E, Lako A, Lim K, Conway J, Tewari AK, Zeng Z, Sahu AD, Tokheim C, Weirather JL, Fu J, Zhang Y, Kroger B, Liang JH, Cejas P, Freeman GJ, Rodig S, Long HW, Gewurz BE, Hodi FS, Brown M, Liu XS. Gu SS, et al. Among authors: tewari ak. Cancer Discov. 2021 Jun;11(6):1524-1541. doi: 10.1158/2159-8290.CD-20-0812. Epub 2021 Feb 15. Cancer Discov. 2021. PMID: 33589424 Free PMC article.
Diagnostic Performance and Safety of Positron Emission Tomography with 18F-rhPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prostate Cancer: Results from a Phase 3, Prospective, Multicentre Study (LIGHTHOUSE).
Surasi DS, Eiber M, Maurer T, Preston MA, Helfand BT, Josephson D, Tewari AK, Somford DM, Rais-Bahrami S, Koontz BF, Bostrom PJ, Chau A, Davis P, Schuster DM, Chapin BF; LIGHTHOUSE Study Group. Surasi DS, et al. Among authors: tewari ak. Eur Urol. 2023 Oct;84(4):361-370. doi: 10.1016/j.eururo.2023.06.018. Epub 2023 Jul 5. Eur Urol. 2023. PMID: 37414702 Free article.
AUTHOR REPLY.
Shukla D, Simma-Chiang V, Kyprianou N, Tewari AK, Lundon DJ. Shukla D, et al. Among authors: tewari ak. Urology. 2021 Nov;157:70. doi: 10.1016/j.urology.2021.04.052. Urology. 2021. PMID: 34895605 No abstract available.
Pseudouridine as a novel biomarker in prostate cancer.
Stockert JA, Weil R, Yadav KK, Kyprianou N, Tewari AK. Stockert JA, et al. Among authors: tewari ak. Urol Oncol. 2021 Jan;39(1):63-71. doi: 10.1016/j.urolonc.2020.06.026. Epub 2020 Jul 22. Urol Oncol. 2021. PMID: 32712138 Free PMC article. Review.
Hood Technique for Robotic Radical Prostatectomy-Preserving Periurethral Anatomical Structures in the Space of Retzius and Sparing the Pouch of Douglas, Enabling Early Return of Continence Without Compromising Surgical Margin Rates.
Wagaskar VG, Mittal A, Sobotka S, Ratnani P, Lantz A, Falagario UG, Martini A, Dovey Z, Treacy PJ, Pathak P, Nair S, Roy B, Chakravarty D, Lewis S, Haines K 3rd, Wiklund P, Tewari A. Wagaskar VG, et al. Among authors: tewari a. Eur Urol. 2021 Aug;80(2):213-221. doi: 10.1016/j.eururo.2020.09.044. Epub 2020 Oct 14. Eur Urol. 2021. PMID: 33067016
Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancer.
Cejas P, Xie Y, Font-Tello A, Lim K, Syamala S, Qiu X, Tewari AK, Shah N, Nguyen HM, Patel RA, Brown L, Coleman I, Hackeng WM, Brosens L, Dreijerink KMA, Ellis L, Alaiwi SA, Seo JH, Baca S, Beltran H, Khani F, Pomerantz M, Dall'Agnese A, Crowdis J, Van Allen EM, Bellmunt J, Morrisey C, Nelson PS, DeCaprio J, Farago A, Dyson N, Drapkin B, Liu XS, Freedman M, Haffner MC, Corey E, Brown M, Long HW. Cejas P, et al. Among authors: tewari ak. Nat Commun. 2021 Oct 1;12(1):5775. doi: 10.1038/s41467-021-26042-z. Nat Commun. 2021. PMID: 34599169 Free PMC article.
A patient-driven clinicogenomic partnership for metastatic prostate cancer.
Crowdis J, Balch S, Sterlin L, Thomas BS, Camp SY, Dunphy M, Anastasio E, Shah S, Damon AL, Ramos R, Sosa DM, Small IK, Tomson BN, Nguyen CM, McGillicuddy M, Chastain PS, He MX, Cheung ATM, Wankowicz S, Tewari AK, Kim D, AlDubayan SH, Dowdye A, Zola B, Nowak J, Manarite J, Gunn IH, Olson B, Lander ES, Painter CA, Wagle N, Van Allen EM. Crowdis J, et al. Among authors: tewari ak. Cell Genom. 2022 Sep 14;2(9):100169. doi: 10.1016/j.xgen.2022.100169. Epub 2022 Aug 19. Cell Genom. 2022. PMID: 36177448 Free PMC article.
913 results